Superovulation using recombinant human FSH and ultrasound-guided transabdominal follicular aspiration in baboon (Papio anubis).
The response of baboon females to a modified human ovarian stimulation protocol incorporating start of pituitary suppression in the luteal phase of the cycle with a GnRH agonist (GnRHa) and recombinant human FSH (rhFSH) was studied. A long-acting GnRHa implant supplying goserelin acetate was administered s.c. to six adult female baboons experiencing regular menstrual cycles (33-34 days) on days 22-24 of the cycle. Follicular development was monitored by transabdominal ultrasonography and serum levels of E2 and progesterone (P4) and rhFSH were determined by ELISA. Menses occurred 9-10 days after GnRHa administration. Daily i.m. administration of 75 IU rhFSH commenced 9-10 days after menses and continued for 9-10 days. When most follicles were > or =5mm diameter and serum E2 had reached its maximum level, 2000 IU hCG was administered i.m. to induce follicle maturation. Transabdominal ultrasound-guided follicular aspiration of follicles > or =2mm diameter was performed 30-34h after hCG administration. One baboon did not show an adequate response to rhFSH stimulation. This animal did not receive further treatment and no data for it are presented. The number of follicles aspirated was 21+/-4 and 17.2+/-3.8 oocytes were recovered per animal with an average recovery rate of 82% (86/105). The number of oocytes collected from five animals were 14, 21, 16, 15, and 20 (n=86). Most of the oocytes recovered were in metaphase II and 3h after recovery 91% (78/86) were considered suitable for in vitro fertilization. It was concluded that recombinant human FSH can successfully induce follicular recruitment and oocyte maturation in baboon females during pituitary suppression with a GnRHa
Cseh
S
S
Department of Obstetrics and Gynecology, School of Medicine, Loma Linda University, CA 92350, USA. scseh@univet.hu
Corselli
J
J
Chan
P
P
Bailey
L
L
D000818:Animals; D004343:Drug Implants; D005260:Female; D005640:Follicle Stimulating Hormone / Q000008:administration & dosage*; D017273:Goserelin / Q000008:administration & dosage; D006801:Humans; D009865:Oocytes; D006080:Ovarian Follicle / Q000166:cytology; D010215:Papio / Q000502:physiology*; D011994:Recombinant Proteins / Q000008:administration & dosage; D013396:Suction / Q000379:methods; D013480:Superovulation; D020858:Tissue and Organ Harvesting / Q000379:methods / Q000662:veterinary*; D014463:Ultrasonography
D004343:Drug Implants; D011994:Recombinant Proteins; D017273:Goserelin; D005640:Follicle Stimulating Hormone